Alec Barclay - Feb 20, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Operations Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2022
Transactions value $
-$2,458
Form type
4
Date filed
2/23/2022, 06:42 PM
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +10K +13.44% 84.4K Feb 21, 2021 Direct F1
transaction TTOO Common Stock Tax liability -$2.46K -5.28K -6.25% $0.47 79.1K Feb 21, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +600K $0.00 600K Feb 20, 2022 Common Stock 600K Direct F1, F3
transaction TTOO Restricted Stock Units Options Exercise $0 -10K -100% $0.00* 0 Feb 21, 2022 Common Stock 10K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 5,275 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F3 On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal annual installments commencing on February 20, 2022.
F4 On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments commencing on February 21, 2020..